Celldex Therapeutics, Inc. - COM NEW (CLDX)

Q3 2022 13F Holders as of 9/30/2022

Type / Class
Equity / COM NEW
Number of holders
145
Total Shares
49.3M
Shares change
+988K
Total reported value, excl. options
$1.39B
Value change
+$32.3M
Put/Call ratio
0.37
Number of buys
76
Number of sells
-60
Price
$28.11
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.